Trial Profile
A Post-marketing Surveillance Looking at Safety and Adherence to Treatment of Enbrel in Adults With Active Rheumatoid Arthritis in Luxemburg.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jan 2012
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Pfizer; Wyeth
- 21 Jan 2012 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 21 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Apr 2011 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov.